ADAM24 Inhibitors

Chemical inhibitors of ADAM24 include a range of compounds primarily recognized for their ability to target metalloprotease domains, which are crucial for the proteolytic function of ADAM24. Marimastat, a broad-spectrum matrix metalloprotease inhibitor, can inhibit ADAM24 by engaging with its MMP-like protease domain, thus interfering with its capacity to process substrates. Similarly, TAPI-1, known for inhibiting tumor necrosis factor-alpha converting enzyme (TACE), which is structurally similar to ADAM proteases, can inhibit the protease activity of ADAM24.

Further, compounds like Ilomastat and its equivalent GM6001, along with Batimastat, can inhibit ADAM24's proteolytic action by chelating the zinc ion within the enzyme's active site. This chelation is a critical step as it prevents the necessary coordination of the metal ion with substrate molecules, leading to the inhibition of substrate cleavage. Prinomastat also inhibits ADAM24 by a similar mechanism of targeting the protease domain, obstructing the enzymatic processing of substrates. SB-3CT, an inhibitor of gelatinases, can inhibit ADAM24 by disrupting the function of its protease domain, which is essential for its activity. Additionally, WAY-170523, which is a selective inhibitor of MMP-13, can inhibit ADAM24 by binding to its metalloprotease domain, albeit this inhibitor is known for its selectivity towards MMP-13, the inhibition mechanism can be extrapolated to ADAM24 due to the similarities in the protease domains. Lastly, PD166793, another MMP inhibitor, can inhibit ADAM24 by directly binding to its catalytic domain, thus impeding the protease's action on its substrates, demonstrating a direct mechanism of inhibition. These chemical inhibitors engage directly with the functional domains of ADAM24, leading to an inhibition of its proteolytic functions without altering protein expression levels.